General Practice · Glendale, CA
NPI
1447396809
Since 2007
Specialty
General Practice
Code 208D00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1030 S Glendale Ave Ste 304
Glendale, CA, 91205
Phone (818) 291-4041
Groups this clinician bills Medicare through
Medicare paid, 2024
$258K
4,990 services
Medicare patients, 2024
635
Average age 77
Drug cost, 2024
$3.6M
30,346 prescriptions
Company payments, 2025
$2,051
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vachik Shahnazarian was code 99213 (office e&m - established), 1,634 times for 563 patients. In total Vachik Shahnazarian billed 4,990 services in 43 codes, and Medicare paid $258K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-12-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,634 | 563 | $67.14 | $110K |
| 36415 Venipuncture Blood Collection | Office | 440 | 284 | $8.65 | $3,806 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 374 | 374 | $21.10 | $7,891 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 364 | 364 | $21.10 | $7,679 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 363 | 363 | $140.13 | $51K |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 342 | 342 | $26.79 | $9,162 |
| G0008 Administration of influenza virus vaccine | Office | 194 | 190 | $35.02 | $6,794 |
| 99212 Office E&M - Established | Office | 192 | 148 | $40.90 | $7,853 |
| 90658 Vaccine Product | Office | 160 | 160 | $21.42 | $3,427 |
| 99406 Behavioral Health Services | Office | 146 | 82 | $15.57 | $2,273 |
| 69210 Other Organ Systems | Office | 136 | 118 | $35.13 | $4,777 |
| 99214 Office E&M - Established | Office | 132 | 114 | $101.13 | $13K |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 123 | 108 | $26.78 | $3,294 |
| 93000 Electrocardiogram | Office | 49 | 47 | $11.14 | $546 |
| 96372 Injection Administration | Office | 40 | 24 | $11.31 | $452 |
By year: 2022 $266K for 5,480 services; 2023 $258K for 5,050 services; 2024 $258K for 4,990 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 440 | 284 | $8.65 | $3,806 |
| 82962 Clinical Chemistry | 32 | 29 | $3.21 | $103 |
Medicare prescription drug claims, 2024
In 2024, the drug Vachik Shahnazarian prescribed most often to Medicare patients was Atorvastatin Calcium, with 2,099 prescriptions and refills. In total Vachik Shahnazarian wrote 30,346 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 2,099 | 2,864 | 269 | $6,059 |
| Sertraline Hcl Generic | 1,064 | 1,365 | 128 | $2,210 |
| Gabapentin Generic | 1,046 | 1,376 | 141 | $3,185 |
| Amlodipine Besylate Generic | 972 | 1,318 | 136 | $1,559 |
| Rosuvastatin Calcium Generic | 926 | 1,268 | 117 | $5,260 |
| Levothyroxine Sodium Generic | 924 | 1,167 | 108 | $3,832 |
| Vascepa Icosapent Ethyl | 869 | 1,108 | 134 | $278K |
| Losartan Potassium Generic | 856 | 1,256 | 122 | $3,239 |
| Metformin Hcl Generic | 850 | 1,125 | 105 | $17K |
| Donepezil Hcl Generic | 838 | 1,089 | 102 | $2,442 |
| Icosapent Ethyl Generic | 821 | 1,022 | 152 | $138K |
| Tamsulosin Hcl Generic | 657 | 875 | 88 | $3,541 |
| Pantoprazole Sodium Generic | 602 | 743 | 75 | $5,221 |
| Lisinopril Generic | 558 | 803 | 84 | $771 |
| Omeprazole Generic | 502 | 609 | 72 | $1,366 |
Brand drugs: 5,330 claims; generic drugs: 24,730 claims; opioid claims: 48.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vachik Shahnazarian $2,051 ($2,051 in general payments such as food, travel and fees) from 20 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $389.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 19 | $389 |
| Amgen Inc. AMGN | 11 | $343 |
| Ardelyx, Inc. ARDX | 8 | $195 |
| Novo Nordisk Inc NVO | 4 | $163 |
| GlaxoSmithKline, LLC. GSK | 7 | $140 |
| Sumitomo Pharma America, Inc. 4506.T | 5 | $128 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $119 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $88.3 |
| Lilly USA, LLC LLY | 3 | $74.59 |
| Abbvie Inc. ABBV | 3 | $59.95 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.